Glycosidic enzymes enhance retinal transduction following intravitreal delivery of AAV2

Molecular Vision

Volumn 17, Issue , 2011, Pages 1771-1783

  Cehajic Kapetanovic, Jasmina ^a,b   le Goff, Magali M ^a   Allen, Annette ^a   Lucas, Robert J ^a   Bishop, Paul N ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CHONDROITIN ABC LYASE; COLLAGENASE; ENHANCED GREEN FLUORESCENT PROTEIN; HEPARIN LYASE; HYALURONIC ACID LYASE; LYASE; PARVOVIRUS VECTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; ELECTRORETINOGRAPHY; GENE THERAPY; GENETIC TRANSDUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RETINA GANGLION CELL; VIRAL GENE DELIVERY SYSTEM;

ACTINS; ANIMALS; CHICKENS; CHONDROITIN ABC LYASE; DEPENDOVIRUS; DRUG COMBINATIONS; DRUG SYNERGISM; ELECTRORETINOGRAPHY; FLUORESCENCE; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; INTRAVITREAL INJECTIONS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; MICROTOMY; POLYSACCHARIDE-LYASES; RECOMBINANT FUSION PROTEINS; RETINA; TRANSDUCTION, GENETIC;

EID: 79960731801     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Surace EM, Auricchio A. Versatility of AAV vectors for retinal gene transfer. Vision Res 2008; 48:353-9.
2. Bainbridge JW, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K, Viswanathan A, Holder GE, Stockman A, Tyler N, Petersen-Jones S, Bhattacharya SS, Thrasher AJ, Fitzke FW, Carter BJ, Rubin GS, Moore AT, Ali RR. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 2008; 358:2231-9.
3. Maguire AM, Simonelli F, Pierce EA, Pugh EN Jr, Mingozzi F, Bennicelli J, Banfi S, Marshall KA, Testa F, Surace EM, Rossi S, Lyubarsky A, Arruda VR, Konkle B, Stone E, Sun J, Jacobs J, Dell'Osso L, Hertle R, Ma JX, Redmond TM, Zhu X, Hauck B, Zelenaia O, Shindler KS, Maguire MG, Wright JF, Volpe NJ, McDonnell JW, Auricchio A, High KA, Bennett J. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 2008; 358:2240-8.
4. Cideciyan AV, Hauswirth WW, Aleman TS, Kaushal S, Schwartz SB, Boye SL, Windsor EA, Conlon TJ, Sumaroka A, Pang JJ, Roman AJ, Byrne BJ, Jacobson SG. Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year. Hum Gene Ther 2009; 20:999-1004.
5. Petrs-Silva H, Dinculescu A, Li Q, Min SH, Chiodo V, Pang JJ, Zhong L, Zolotukhin S, Srivastava A, Lewin AS, Hauswirth WW. High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors. Mol Ther 2009; 17:463-71.
6. Bishop PN. Structural macromolecules and supramolecular organisation of the vitreous gel. Prog Retin Eye Res 2000; 19:323-44.
7. Halfter W, Dong S, Dong A, Eller AW, Nischt R. Origin and turnover of ECM proteins from the inner limiting membrane and vitreous body. Eye 2008; 22:1207-13.
8. Inatani M, Tanihara H. Proteoglycans in retina. Prog Retin Eye Res 2002; 21:429-47.
9. Hollyfield JG, Rayborn ME, Tammi R. Hyaluronan localization in tissues of the mouse posterior eye wall: absence in the interphotoreceptor matrix. Exp Eye Res 1997; 65:603-8.
10. Li Q, Miller R, Han PY, Pang J, Dinculescu A, Chiodo V, Hauswirth WW. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential. Mol Vis 2008; 14:1760-9.
11. Russell SR, Shepherd JD, Hageman GS. Distribution of glycoconjugates in the human retinal internal limiting membrane. Invest Ophthalmol Vis Sci 1991; 32:1986-95.
12. Chai L, Morris JE. Distribution of heparan sulfate proteoglycans in embryonic chicken neural retina and isolated inner limiting membrane. Curr Eye Res 1994; 13:669-77.
13. Heegaard S, Jensen OA, Prause JU. Structure and composition of the inner limiting membrane of the retina. SEM on frozen resin-cracked and enzyme-digested retinas of Macaca mulatta. Graefes Arch Clin Exp Ophthalmol 1986; 224:355-60.
14. Nishihara H. Studies on the ultrastructure of the inner limiting membrane of the retina-distribution of anionic sites in the inner limiting membrane of the retina. Nippon Ganka Gakkai Zasshi 1991; 95:951-8.
15. Herzer S, Beckett P, Wegman T, Moore P. Isoelectric titration curves of viral particles as an evaluation tool for ion exchange chromatography. Life Science News 13, Amersham Biosciences 2003.
16. Sakurai E, Ozeki H, Kunou N, Ogura Y. Effect of particle size of polymeric nanospheres on intravitreal kinetics. Ophthalmic Res 2001; 33:31-6.
17. Nishihara H. Studies on the ultrastructure of the inner limiting membrane of the retina. I. Surface replication study on the inner limiting membrane of the retina. Nippon Ganka Gakkai Zasshi 1989; 93:429-38.
18. Kamei M, Misono K, Lewis H. A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits. Am J Ophthalmol 1999; 128:739-46.
19. Kronenberg S, Kleinschmidt JA, Bottcher B. Electron cryomicroscopy and image reconstruction of adeno-associated virus type 2 empty capsids. EMBO Rep 2001; 2:997-1002.
20. Mordenti J, Cuthbertson RA, Ferrara N, Thomsen K, Berleau L, Licko V, Allen PC, Valverde CR, Meng YG, Fei DT, Fourre KM, Ryan AM. Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125I-labelled fulllength and Fab antibodies in rhesus monkeys following intravitreal administration. Toxicol Pathol 1999; 27:536-44.
21. Jackson TL, Antcliff RJ, Hillenkamp J, Marshall J. Human retinal molecular weight exclusion limit and estimate of species variation. Invest Ophthalmol Vis Sci 2003; 44:2141-6.
22. Lebherz C, Maguire A, Tang W, Bennett J, Wilson JM. Novel AAV serotypes for improved ocular gene transfer. J Gene Med 2008; 10:375-82.
23. Kolstad KD, Dalkara D, Guerin K, Visel M, Hoffmann N, Schaffer DV, Flannery JG. Changes in adeno-associated virus mediated gene delivery in retinal degeneration. Hum Gene Ther 2010; 21:571-8.
24. Park TK, Wu Z, Kjellstrom S, Zeng Y, Bush RA, Sieving PA, Colosi P. Intravitreal delivery of AAV8 retinoschisin results in cell type-specific gene expression and retinal rescue in the Rs1-KO mouse. Gene Ther 2009; 16:916-26.
25. Grüter O, Kostic C, Crippa SV, Perez MT, Zografos L, Schorderet DF, Munier FL, Arsenijevic Y. Lentiviral vectormediated gene transfer in adult mouse photoreceptors is impaired by the presence of a physical barrier. Gene Ther 2005; 12:942-7.
26. Dalkara D, Kolstad KD, Caporale N, Visel M, Klimczak RR, Schaffer DV, Flannery JG. Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous. Mol Ther 2009; 17:2096-102.
27. Singhal S, Lawrence JM, Bhatia B, Ellis JS, Kwan AS, Macneil A, Luthert PJ, Fawcett JW, Perez MT, Khaw PT, Limb GA. Chondroitin sulfate proteoglycans and microglia prevent migration and integration of grafted Müller stem cells into degenerating retina. Stem Cells 2008; 26:1074-82.
28. Kern A, Schmidt K, Leder C, Müller OJ, Wobus CE, Bettinger K, Von der Leith CW, King JA, Kleinschmidt JA. Identification of a heparin-binding motif on adenoassociated virus type 2 capsids. J Virol 2003; 77:11072-81.
29. Boyle MP, Enke RA, Reynolds JB, Mogayzel PJ Jr, Guggino WB, Zeitlin PL. Membrane-associated heparan sulfate is not required for rAAV-2 infection of human respiratory epithelia. Virol J 2006; 3:29.
30. Bishop PN. Vitreous as a substrate for vitreolysis. Dev Ophthalmol 2009; 44:7-19.
31. Gottlieb JL, Antoszyk AN, Hatchell DL, Saloupis P. The safety of intravitreal hyaluronidase: a clinical and histologic study. Invest Ophthalmol Vis Sci 1990; 31:2345-52.
32. Staubach F, Nober V, Janknecht P. Enzyme-assisted vitrectomy in enucleated pig eyes: a comparison of hyaluronidase, chondroitinase, and plasmin. Curr Eye Res 2004; 29:261-8.
33. Kuppermann BD, Thomas EL, de Smet MD, Grillone LR. Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Am J Ophthalmol 2005; 140:585-97.